Your cart is currently empty!
Nabcure (Paclitaxel) Injection
Generic brands for Paclitaxel Injection Available in India Brand Name Nabcure Generic Name Paclitaxel Strength 100mg Manufacturer Emcure Pharmaceuticals Ltd
Description
Description
This page contains brief details about the drug paclitaxel, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Paclitaxel is a chemotherapeutic anticancer treatment drug which was approved for its medical use on December 1992.
Mechanism of Action of Paclitaxel
Paclitaxel is a chemotherapeutic agent that belongs to the category of medications called microtubule inhibitors. microtubules are structures that aid in the growth and development of cancer cells. Paclitaxel works by inhibiting these structures, ultimately stopping the multiplication of cancer cells. Paclitaxel is prescribed alone and also in combination with other anticancer medications.
Uses of Paclitaxel
Paclitaxel has been developed to treat certain forms of breast cancer, ovarian cancer, non-small cell lung cancer and AIDS-induced Kaposis sarcoma in patients who have not responded well to previous anticancer therapies.
Paclitaxel Dosage available
Paclitaxel is available in the form of injection in the doses 30mg, 100mg, 260mg and 300mg. Your healthcare provider will calculate the ideal dose according to your condition and administer it as an intravenous infusion after dilution.
News/Updates
References
1. Anton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Goodman & Gilman’s Pharmacological Basis of Therapeutics, Cytotoxic Drugs, 13th Edition, 2018, 1167-1201.
2. Pfizer, [Revised on Apr 2021] [Accessed on 5th Oct 2022], https://labeling.pfizer.com/ShowLabeling.aspx?id=4559
3. Abraxis BioScience, LLC., [Revised on Aug 2020] [Accessed on 5th Oct 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021660s047lbl.pdf